UNSPSC 51132226: Aluminum hydroxide/aspirin/calcium carbonate/magnesium hydroxide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN103. This VA Drug Class (CN103) classifies this compound as belonging to the group NON-OPIOID ANALGESICS.

UNSPSC 51132226 Aluminum hydroxide/aspirin/calcium carbonate/magnesium hydroxide is a Commodity code, but the recent state and local activity posted under it does not reflect pharmaceutical antacids or analgesics. Instead, Seminole County, Florida is soliciting naloxone and safe drug deactivation systems — opioid-reversal medications and harm-reduction equipment wholly unrelated to the code's nominal scope. This mismatch suggests either a data-entry error in tagging or a broader cataloging inconsistency in the jurisdiction's procurement system. The code shows no meaningful recent activity aligned with its stated product classification.

Seminole County released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline (an apparent data inconsistency in the source). Quarterly deliveries were to go to the Seminole County Community Health Building in Sanford, Florida, with vendors required to cover all shipping and delivery costs. The contract carried a two-year initial term plus one-year renewal option and included standard compliance requirements such as drug-free workplace certification, E-Verify enrollment, and federal environmental regulation adherence. Without additional recent opportunities tagged to this code from other state and local jurisdictions, no meaningful geographic spread or issuing-body pattern can be established. Firms should treat this code as misaligned with actual purchasing intent in current state and local markets and verify UNSPSC classification before pursuit.